MAQUET Cardiovascular has announced it has received FDA 510(k) clearance for its new MEGA 7.5Fr. 30cc and 40cc intra-aortic balloon catheters, according to a news release.
The company said the larger volume catheters are designed to allow clinicians to provide patients with greater hemodynamic support, regardless of their height and also help displace more blood in the aorta during diastole.
"The MEGA family of catheters represents a true advancement in intra-aortic balloon therapy and broadens our therapeutic offerings for clinicians and patients, as these new catheters deliver a significant increase in hemodynamic support regardless of the patient's height," said Christian Keller, president and CEO of MAQUET Cardiovascular, in the release. "As a global leader in hemodynamic support, MAQUET is committed to advancing IAB therapy, and we are confident that our larger volume balloons will remain the gold standard for clinicians when such support is needed."
MAQUET Cardiovascular is headquartered in Wayne, N.J.
Related Articles on FDA Clearances:
Hitachi Receives FDA Clearance for Echelon Oval MR System
ProUroCare Receives FDA 510(k) Clearance for Prostate Imaging System
Toshiba Receives FDA 510(k) Clearance for Aquilion PRIME 80 Series CT System